ENG

  • Ted HU

    Equity Partner / Shanghai

  • Tel +86-21-6061-3666

    Email tedhu@zhonglun.com

  • Practices

    Chinese Mainland Capital Markets, Private Equity & Investment Funds, Investment/M&A & Corporate Governance

  • Industries

    Healthcare, Pharmaceuticals & Life Sciences, Energy & Power

CV

Ted HU

Yinzi Hu has been specializing in and focusing on the capital market, M&A and private equity investment since his practice in 2011. He has rich practical experience in various types of domestic or cross-border transactions including mergers and acquisitions, investment and financing, restructuring and reformation, equity incentives, securities issuance and state-owned assets transactions. He is familiar with a wide range of industries covering pharmaceuticals and healthcare, energy and power, real estate, urban infrastructure, industry and manufacturing, and others. Most of his clients are domestic and overseas listed companies, large state-owned enterprises, investment institutions and innovative enterprises. Some of those transactions handled by him was listed of Deals of the Year by China Business Law Journal or IFLR1000 China Awards or was regarded as landmark projects in relevant industry. Ted Hu is expert at tailoring the transaction structure according to commercial needs, identifying various legal and commercial issues and putting forward constructive solutions. He is adept at handling large and complex transactions and dealing with various pressures and changes, helping his clients effectively control risks and facilitate the conclusion of transactions, winning praise from clients with his professional, dedicated, patient and efficient legal services

Representative Matters

Capital Markets/Securities

  • Acted as issuer’s counsel, provided legal service for SIIC Environment Holdings Ltd. (0807.HK;BHK.SG) in its dual listing on the main board of the HKEX

  • Acted as issuer’s counsel, provided legal service for Shanghai Electric Power Co., Ltd. (600021.SH) in its non-public issuance of A Shares to raise funds to invest in several offshore wind power projects

  • Acted as issuer’s counsel, provided legal service for Shanghai Industrial Urban Development Group Limited (0563.HK) in its reverse takeover of Shanghai Urban Development (Holdings) Co., Ltd. involving new listing on the main board of the HKEX (the case was regarded as a typical case by HKEx)

  • Acted as issuer’s counsel, provided legal service for Goldenmars Technology Holdings Limited (08036.HK) in its listing on the growth enterprise market of HKEx

  • Acted as issuer’s counsel, provided legal service for Shanghai Industrial Holdings Limited (0363.HK) in its issuance of HK$3,900,000,000 Zero Coupon Convertible Bonds

  • Acted as issuer’s counsel, provided legal service for Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) in its listing on the main board of the HKEX


Investment/M&A in Pharmaceuticals and Healthcare

  • Represented Shanghai Pharmaceuticals Holding Co., Ltd (601607.SH/2607.HK) in its acquisition of Cardinal Health Inc.’s (NYSE:CAH) China Business (this transaction was awarded Deals of the Year 2018 by China Business Law Journal)

  • Represented Shanghai Pharmaceuticals Holding Co., Ltd (601607.SH/2607.HK) in its acquisition of Techpool Bio-Pharma Co., Ltd. from Takeda Pharmaceutical Company Limited (TYO:4502)

  • Represented Sinopharm Group Co. Ltd.(01099.HK) in its acquisition of 60% equity interest in China National Scientific Instruments and Materials Co., Ltd. held by CNPGC

  • Represented Shanghai SPH Ruier Drugs Co., Ltd. in its acquisition of Foshan Kaichuan Pharma Co., Ltd.

  • Represented CNNC Medical Investment Management Co., Ltd., a subsidiary of CNNC, in its acquisition of several medical imaging center operating entities

  • Represented Shanghai Pharmaceutical Co., Ltd. in its establishment of a third-party logistics joint venture with DHL China

  • Represented Sequoia Capital in its leading investment in BoomRay’s round A financing of nearly CNY 300 million

  • Represented BioVeda China Fund in its investment in CARsgen Therapeutics of tens of millions CNY 

  • Represented CD Capital in its investment in Righton Gene’ s round A financing of more than CNY 100 million

  • Represented BioVeda China Fund in its investment in Allgens’ round C financing of CNY 70 million

  • Represented Shanghai Pharma (601607.SH) in its leading investment in Overseas Pharma’s round C financing of CNY 150 million

  • Assisted SPH Health Commerce Co., Ltd to complete its CNY 1.112 billion of round A financing (investors include JD.com and IDG), hundreds of millions of yuan of round A+ financing (investors include Softbank and others) and 1.033 billion yuan of round B financing (investors include Shanghai Healthcare Capital, JIC Investment and others)

  • Assisted Biocytogen to complete its D+ round financing of CNY 970 million

  • Assisted Doma Biopharma in its establishment and completion of round A financing of CNY 950 million

  • Assisted Eucure Biopharma in its establishment and completion of several rounds of equity financing

  • Assisted Genova Inc. to complete its round B financing of USD 50 million

  • Assisted DiaCarta to complete its round B financing of more than USD 40 million

  • Assisted InnoMed to complete its round C financing of more than CNY 100 million

  • Assisted LongBio to complete its round A and A+ financing of more than CNY 100 million

  • Assisted Shanghai Pharma, Chia Tai Tianqing, CSPC Pharma and other pharmaceutical enterprises in their various BD transactions including market authorization, intellectual property, sales rights, industrial rights by providing legal due diligence and transaction documents drafting services


Investment/M&A in Power and Energy

  • Represented Yunnan Provincial Energy Investment Group Co., Ltd. in its establishment of an industrial M&A fund and completion of the acquisition of 23 photovoltaic power generation projects in Hebei and Shanxi under GCL New Energy Holdings Limited (0451.HK) (with a total installed capacity of 969.47MW)

  • Represented China Three Gorges Corporation (CTGC) and its subsidiaries to acquire dozens of wind and photovoltaic power generation project companies in Hunan, Shaanxi, Inner Mongolia, Hebei, Shandong, Liaoning and other places

  • Represented Xinhua Electricity Development Investment Limited, a subsidiary of China National Nuclear Corporation (CNNC), in its acquisition of dozens of wind and photovoltaic power generation project companies in Gansu, Xinjiang, Tianjin, Hebei, Shanxi, Qinghai, Inner Mongolia, Yunnan, Jiangsu and other places from Kong Sun Holdings Limited (0295.HK) and other HKEx listed companies

  • Represented Shanghai Industrial Holdings Limited (0363.HK) in its establishment of a JV with HT-SAAE (600151.SH) and represented the JV in its acquisition of several photovoltaic power generation plants in Gansu, Xinjiang, Qinghai and Ningxia.

  • Represented Beijing Energy International Holding Co. , Ltd. (0686. HK) in its acquisition of dozens of wind and photovoltaic power station projects in Anhui, Hebei, Hubei, Shaanxi, Liaoning, Inner Mongolia, Guangdong and other places

  • Represented Shanghai Electric Power Co., Ltd. (600021. SH) and its affiliates in their completion of  investment in Shanghai Sunwise New Energy System Co., Ltd. by capital increase of RMB 192 million and obtaining its 33.8% equity (the company is an important domestic supplier of overall solutions and key equipment for hydrogen system and the builder of hydrogen energy supply service chain)

  • Representation an HKEx listed company in its acquisition of several industrial and commercial rooftop distributed photovoltaic power generation projects and charging pile projects under a PRC energy storage technology development company 

  • Representing an HKEx listed company in its establishment of PRC project management headquarter and investment operation platform, and completion of acquisition of several PRC photovoltaic power generation projects

  • Represented Zhongneng Integrated Smart Energy Technology Co., Ltd. in its establishment of a joint venture with a smart power operation and maintenance enterprise

  • Represented SIIC Shanghai Investment (Group) Co., Ltd. in its completion of capital increase in Shanghai Electric Power Trading Center Co., Ltd

  • Represented Sequoia Capital to lead the investment in a PRC energy storage technology research and development enterprise


Investment/M&A in Real Estate

  • Assisted Shanghai Industrial Urban Development Group Limited (0563.HK) in its acquisition of Shanghai Urban Development (Group) Co., Ltd, the transaction amount of which is 6.11 billion HK dollars. This case was regarded as a typical case by HKEx for it constituting very substantial acquisition and new listing

  • Assisted Shanghai Industrial Urban Development Group Limited (0563.HK) in its acquisition of Shanghai World Trade Center Co., Ltd, the transaction amount of which was USD 579.3 million (the target holds Shanghai Mart property, which is the first permanent international trade city in China, with a total floor area of more than 280,000 square meters)

  • Represented Taiping Insurance in its acquisition of a commercial real estate in Beijing, the transaction amount of which was CNY 1.8 billion

  • Represented an equity investment fund in its acquisition of an industrial real estate project in Shanghai

  • Represented a trust company in its establishment of several trust and completion of investment in several real estate projects

  • Represented several fund management companies in their establishment of real estate fund and completion of investment in several real estate projects

  • Assisted Shanghai Industrial Urban Development Group Limited (0563.HK) in its sale of 60% equity interest in Shanghai Huanyu Urban Investment and Development Co., Ltd. the transaction amount of which was CNY 3.576 billion (the company holds a proposed composite commercial development located in Shanghai Xuhui District occupying a total site area of approximately 77,370.5 sq.m)


Investment/M&A in Urban Infrastructure

  • Represented SIIC Shanghai Investment (Group) Co., Ltd. in its acquisition of 23.0584% equity interest of Hangzhou Bay Bridge Development Co, Ltd. from Sino-Steel, transaction amount of which is CNY 1.466 billion

  • Represented Shanghai Industrial Holdings Limited (0363.HK) and SIIC Environment Holdings Ltd. (BHK.SG) in their acquisition of Longjing Environmental Protection Group Co., Ltd (which holds 41 projects related to wastewater treatment, water supply and sludge treatment)

  • Represented SIIC Environment Holdings Ltd. in its acquisition of 50% shares of Shanghai Pucheng Thermal Power Co., Ltd., the transaction amount of which is about CNY 530 million

  • Represented SIIC Environment Holdings Ltd. in its acquisition of a garbage power plant located in Dazhou, Sichuan, the transaction amount of which is about CNY 145 million 

  • Represented a fund managed by SIDC Juli Investment Management Co., Ltd. in its completion of investment in Shandong Lunan Borui Hazardous Waste Centralized Disposal Co., Ltd. of nearly CNY 300 million (the company is a comprehensive hazardous waste disposal enterprise with large disposal scale and complete treatment categories in South Shandong area)


Investment/M&A in Other Sectors

  • Assisted Shanghai Oriental Newspaper Co., Ltd. (the operating entity of thePaper.cn) in its completion of round B financing of RMB 400 million

  • Represented Sequoia Capital as the main investor in its participation in the mixed ownership reform  project of Guangzhou G-Gas Energy Co., Ltd

  • Represented a USD investment fund in its investment in AutoX, an auto-driving technology enterprise by convertible bonds

  • Represented an RMB fund in its investment in Shanghai Lingyun Microelectronics Co., Ltd., a semiconductor technology enterprise

  • Represented Shanghai Galaxy Investment Co., Ltd. and its affiliates in their investment in Zhejiang Wufangzhai Industrial Co., Ltd.

  • Represented Shanghai Galaxy Investment Co., Ltd. in its investment in Shanghai Zhenchen Finance Leasing Co., Ltd


Private Equity & Investment Funds

  • Represented several PE investment fund management institutions including Sequoia Capital, Matrix China, CD Capital, BioVeda China Fund, Infinity Equity, Lake Ventures in their numbers of PE investment projects in various innovative technology enterprises, and assisted in the following rounds of financing and mergers of the portfolio companies

  • Provided legal services for CD Capital, BioVeda China Fund, Lake Ventures, Ehouse China and other PE investment fund management institutions in their establishment of several PE investment funds and assisted in their following fund management

  • Provided legal services for several large-scale enterprises or institutions in their investment as limited partners in PE investment funds


Honors and Awards

Next Generation Lawyers (Corporate and M&A), The Legal 500 Asia Pacific, 2018

Next Generation Lawyers (Private Equity/Venture Capital), The Legal 500 Asia Pacific, 2019

Deals of the Year 2018(Shanghai Pharmaceuticals on its acquisition of Cardinal China), China Business Law Journal

2021 IFLR1000 China Awards(Shanghai Pharma Health's acquisition of KDL Pharmacy and Baiji Pharmacy)

Publications

ECO-ENVIRONMENTAL LEGAL PRACTICE within the context of the carbon peak and neutrality goals, Research Institute of Zhong Lun Law Firm,2021

New Energy Law Collection of Zhong Lun Law Firm: NEW RULES AND INNOVATION IN VARIABLES,Research Institute of Zhong Lun Law Firm,2021

Related

  • Bar Admissions/Professional Qualifications

    PRC Bar

  • Education

    LL.M, Liverpool John Moores University
    Bachelor of Laws, Bachelor of Econimics, Shanghai Universtiy Law School

  • Professional Experience

    Equity Partner, Non-equity Partner, Zhong Lun Law Firm
    Associate, AllBright Law Offices

  • Languages

    Chinese
    English